MaxCyte, Inc. (MXCT)
1.225
+0.04
(+2.94%)
USD |
NASDAQ |
Sep 21, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
MaxCyte Debt to Equity Ratio : 0.1087 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1087 |
| March 31, 2026 | 0.1042 |
| December 31, 2025 | 0.1046 |
| September 30, 2025 | 0.1007 |
| June 30, 2025 | 0.097 |
| March 31, 2025 | 0.0944 |
| December 31, 2024 | 0.0874 |
| September 30, 2024 | 0.0859 |
| June 30, 2024 | 0.0837 |
| March 31, 2024 | 0.0823 |
| December 31, 2023 | 0.0807 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0689 |
| June 30, 2023 | 0.0673 |
| March 31, 2023 | 0.0656 |
| December 31, 2022 | 0.0634 |
| September 30, 2022 | 0.059 |
| June 30, 2022 | 0.0563 |
| March 31, 2022 | 0.0505 |
| December 31, 2021 | 0.0216 |
| September 30, 2021 | 0.0044 |
| June 30, 2021 | 0.0168 |
| March 31, 2021 | 0.0218 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Azenta, Inc. | 0.0357 |
| Danaher Corp. | 0.5298 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 184.67M |
| Total Liabilities (Quarterly) | 25.92M |
| Shareholders Equity (Quarterly) | 158.75M |
| Current Ratio | 12.26 |
| Net Debt Paydown Yield | 0.24% |